Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-018193
Filing Date
2025-07-08
Accepted
2025-07-08 16:08:38
Documents
27

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm S-1 851919
2 EX-1.1 ex1-1.htm EX-1.1 676670
3 EX-4.20 ex4-20.htm EX-4.20 22266
4 EX-4.21 ex4-21.htm EX-4.21 140876
5 EX-4.22 ex4-22.htm EX-4.22 141185
6 EX-5.1 ex5-1.htm EX-5.1 21029
7 EX-5.2 ex5-2.htm EX-5.2 15515
8 EX-23.1 ex23-1.htm EX-23.1 4321
9 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 101934
10 GRAPHIC formdrs_001.jpg GRAPHIC 20404
11 GRAPHIC formdrs_002.jpg GRAPHIC 117826
12 GRAPHIC formdrs_003.jpg GRAPHIC 46582
13 GRAPHIC formdrs_004.jpg GRAPHIC 41661
14 GRAPHIC formdrs_005.jpg GRAPHIC 6279
15 GRAPHIC ex5-1_001.jpg GRAPHIC 3741
16 GRAPHIC ex5-2_001.jpg GRAPHIC 11881
17 GRAPHIC ex5-2_002.jpg GRAPHIC 11881
  Complete submission text file 0001641172-25-018193.txt   2517921

Data Files

Seq Description Document Type Size
29 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 26202
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: S-1 | Act: 33 | File No.: 333-288562 | Film No.: 251111140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)